PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.37−0.05 (-0.92%)
Close on Nov 18, 2026Market cap $57.65MP/E –Yield –
PharmaCyte Biotech pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
PharmaCyte Biotech's pe ratio was 0.3× on May 29, 2026, against 1.3× a year earlier. Over the last 2 years it ranged from 0.2× to 47.2×, with a median of 1.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | May 29, 2026 | 0.3× | +0.1 |
| 2025 | Dec 31, 2025 | 0.2× | −2.6 |
| 2024 | Dec 31, 2024 | 2.8× | – |
See a number that looks wrong?